Marcel Velterop

Marcel Velterop serves as CEO at Primopus. Primopus operates in the pharmaceuticals sector with approximately 41.0 employees. The company is headquartered in Basel, Basel-Stadt.

Industry & Role Insights

• • MessageCEO tracks 1,288 executives in the pharmaceuticals sector.
• • 259 executive contacts are available in Basel-Stadt.
• • Our database includes 201,468 c suite-level executives.

Outlook reCAPTCHA Mobile Friendly YouTube Apache WordPress.org Google Tag Manager

custom fine chemicals for pharma manufacturing of gmp intermediates process rd & scaleup manufacturing of rsms pharmaceutical manufacturing cmo cdmo api rsm phosphoramidites fmoc amino acids gmp pr&d manufacturing services process development chemical synthesis supply chain management backward integration life-embracing pharma services custom intermediates regulatory compliance quality assurance sustainability environmental impact net zero carbon research & development oligonucleotides drug substance production clinical trial support intermediates supply pharmaceutical industry biotechnology pharmaceutical supply chain hazardous waste management green chemistry automation in manufacturing quality metrics digital gmp regulatory requirements analytical method validation hplc gc quality management system ehs compliance sop development customer focused approach integrity in pharma active pharmaceutical ingredient bespoke contact innovation in pharma collaborative partnerships industry events gmp standards pharma sustainability initiatives pharmaceuticals medical logistics & supply chain environmental services renewables & environment

YM

Yathendra Madineni Chief Executive Officer at 4C Pharma Solutions

RB

Ronan Brown Chief Operating Officer at 4G Clinical

HK

Hitoshi Kamiya Chief Executive Officer at A2 Healthcare Corporation

LJ

Lars Jensen CEO at A-apoteket

TL

Tien Lee CEO at Aardvark Therapeutics, Inc.

Outreach Guidance — pharmaceuticals Sector

Executives like Marcel Velterop in the pharmaceuticals sector receive targeted outreach from sales teams, recruiters, and investors. To stand out, personalize your message with industry-specific context and a clear, specific value proposition relevant to their role at Primopus.

Marcel Velterop's Position in the MessageCEO Database

• •Marcel Velterop is 1 of 1 verified executive contact we track at Primopus.
• •1,240 verified executive contacts in pharmaceuticals are in the MessageCEO database.
• •255 verified executive contacts in Basel-Stadt are in the database.
• •12 verified contacts work at pharmaceuticals companies in the 41.0 employee range (same size as Primopus).

Executive contact data compiled from public business filings, LinkedIn public profiles, company press materials, and verified outbound email testing. We do not publish personal addresses or sensitive identifiers. Methodology & sources · Removal requests handled at /remove-info · Updated July 2026.

How do I reach Marcel Velterop directly?

Marcel Velterop's verified email address is available to MessageCEO Pro subscribers. They currently serve as CEO at Primopus. Access direct contact info to skip gatekeepers and reach the decision maker.

What company does Marcel Velterop work for?

Marcel Velterop is CEO at Primopus, a company in the pharmaceuticals sector with 41.0 employees. The company is based in Basel, Basel-Stadt.

Can I pitch or sell to Marcel Velterop?

As CEO at Primopus, Marcel Velterop is a key decision-maker in the pharmaceuticals sector. MessageCEO Pro gives you verified email to reach Marcel Velterop directly — ideal for B2B sales, partnerships, and executive recruiting.

What industry is Marcel Velterop in?

Marcel Velterop works in the pharmaceuticals industry as CEO at Primopus. MessageCEO provides verified contact information for executives across all major industries.

Is Marcel Velterop's contact information verified?

Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. Marcel Velterop's profile is kept up-to-date with the latest available information.

Last updated: July 31, 2026